Long-term Consequences of Bereavement in Children, Adolescents and Young Adults

August 11, 2014 updated by: Christoffer Johansen, Danish Cancer Society

Bereavement in Children, Adolescents and Young Adults. - A Study of Health and Psychosocial Well-being in Adults Who Have Experienced Early Parental Death

The purpose of this study is to examine how the death of a parent as a child, adolescent or young adult affects health and psychosocial wellbeing in adult life and to evaluate the impact in adult life of counseling to children, adolescents and young adults who lost a parent.

Study Overview

Status

Completed

Conditions

Detailed Description

Early parental death experienced by 4% of the children in Western countries, is considered to be the most stressful and potentially harmful childhood life event and the health consequences may depend on the nature of the bereavement (e.g. relationship with bereaved), as well as by interpersonal (e.g. social support), intrapersonal (e.g. age and genetics), appraisal and coping factors. Studies have shown that children and adolescents have a greater risk of getting a psychiatric diagnose as well as psychological and social problems. Despite of the obvious consequences of losing a parent, there is a lack of systematic studies on the consequences later in life as well as studies that evaluate the counseling possibilities the children and adolescents are offered.

The study will investigate:

  1. Long-term health effects of experiencing parental death as a child adolescent or young adult. Focus will be on psychiatric outcomes including depression, severe cardiovascular disease, suicide, suicide attempts, psychological well-being and health related behavior.
  2. Long term effects of experiencing parental death as a child, adolescent or young adult on socioeconomic outcomes as education, employment, marital status/ cohabitation status and number of children/age when having children.
  3. The long-term psychosocial and behavioral impact of psychological intervention programmes to children, adolescents and young adults who have experienced the death of a parent. Focus will be on: Depressive symptoms, quality of life, posttraumatic stress disorder, life style, relationship functioning, grief and spirituality.

A nationwide register based cohort of people born in Denmark will be established. Long-term health effects and socioeconomic outcomes of experiencing parental death will be based on nationwide clinical and administrative registries. Exposure is defined as experiencing the death of a parent before age 30. The long-term psychosocial and behavioral impact of psychological intervention programmes will be based on a combination of questionnaire data and data from registries.

The part of the study using data from registries will be based on the nationwide cohort. The questionnaire based part of the study will include 3 groups selected from the nationwide cohort:

  1. Persons who have lost a parent and participated in intervention programmes (identified through counseling centers),
  2. Persons who have lost a parent, and not participated in intervention programmes (randomly selected matched on age and gender) and
  3. Persons who have not lost a parent (randomly selected matched on age and gender).

An invitation letter will be send to the 3 groups (5500 persons) by mail, and they will be asked to complete one questionnaire online.

Study Type

Observational

Enrollment (Actual)

1225660

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Copenhagen, Denmark, 2100
        • Department of Psychosocial Cancer Research, Institute of Cancer Epidemiology, Danish Cancer Society

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

11 years and older (Child, Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Nationwide population-based cohort (Denmark)

Description

Inclusion Criteria:

  • persons born in Denmark

Exclusion Criteria:

-

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Hospitalization for affective disorder
Time Frame: Paticipants will be followed from age 15 until date of first hospitalization for an affective disorder, death, first emigration or end of follow up, an expected average of 12 years
Danish Psychiatric Central Register
Paticipants will be followed from age 15 until date of first hospitalization for an affective disorder, death, first emigration or end of follow up, an expected average of 12 years
Use of antidepressive medication
Time Frame: Paticipants will be followed from age 20 until date of second independantly prescription of antidepressive medication, death, first emigration or end of follow up, an expected average of 9 years
The Danish National Prescription Registry
Paticipants will be followed from age 20 until date of second independantly prescription of antidepressive medication, death, first emigration or end of follow up, an expected average of 9 years
Suicide
Time Frame: Paticipants will be followed from age 18 until date of suicide, other causes of death, first emigration or end of follow up, an expected average of 15 years
Danish Register of Causes of Death
Paticipants will be followed from age 18 until date of suicide, other causes of death, first emigration or end of follow up, an expected average of 15 years
Severe cardiovascular disease
Time Frame: Paticipants will be followed from age 18 until date of first hospitalization for severe cardiovascular disease, death, first emigration or end of follow up, an expected average of 15 years
The Danish National Patient Register
Paticipants will be followed from age 18 until date of first hospitalization for severe cardiovascular disease, death, first emigration or end of follow up, an expected average of 15 years
Education level
Time Frame: Participants will be followed from age 18 until highest attained educational level, death, first emigration or end of follow up, an average of 20 years
The Register-based System of Demographics and Social Statistics in Denmark
Participants will be followed from age 18 until highest attained educational level, death, first emigration or end of follow up, an average of 20 years
Employment
Time Frame: Employment status at age 30, death, first emigration or end of follow-up, an expected average of 8 years.
The Register-based System of Demographics and Social Statistics in Denmark
Employment status at age 30, death, first emigration or end of follow-up, an expected average of 8 years.
Quality of life
Time Frame: Participants will be answering the questionnaire once (not at a specifik age but between 18-40 years)
SF-36, Self-reported questionnaire
Participants will be answering the questionnaire once (not at a specifik age but between 18-40 years)
Complicated grief
Time Frame: Participants will be answering the questionnaire once (not at a specifik age but between 18-40 years)
Inventory of Complicated Grief/ Prolonged Grief Disorder (PG-13) and Centrality of Event Scale, Self-reported questionnaire
Participants will be answering the questionnaire once (not at a specifik age but between 18-40 years)
PTSD
Time Frame: Participants will be answering the questionnaire once (not at a specifik age but between 18-40 years)
Harvard Trauma Questionnaire (HTQ), Self-reported questionnaire
Participants will be answering the questionnaire once (not at a specifik age but between 18-40 years)
Existentiality
Time Frame: Participants will be answering the questionnaire once (not at a specifik age but between 18-40 years)
Posttraumatic Growth Inventory (PTGI, Self-reported questionnaire
Participants will be answering the questionnaire once (not at a specifik age but between 18-40 years)
Depressive symptoms
Time Frame: Participants will be answering the questionnaire once (not at a specifik age but between 18-40 years)
The Center for Epidemiological Studies Depression Scale (CES-C)
Participants will be answering the questionnaire once (not at a specifik age but between 18-40 years)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Relationship functioning
Time Frame: Participants will be answering the questionnaire once (not at a specifik age but between 18-40 years)
Quality of relationship and intimacy, Self-reported questionnaire
Participants will be answering the questionnaire once (not at a specifik age but between 18-40 years)
Support when losing a parent
Time Frame: Participants will be answering the questionnaire once (not at a specifik age but between 18-40 years)
Self-report items
Participants will be answering the questionnaire once (not at a specifik age but between 18-40 years)
Lifestyle (smoking, alcohol, exercise)
Time Frame: Participants will be answering the questionnaire once (not at a specifik age but between 18-40 years)
Self-reported questionnaire
Participants will be answering the questionnaire once (not at a specifik age but between 18-40 years)
Coping
Time Frame: Participants will be answering the questionnaire once (not at a specifik age but between 18-40 years)
Brief cope, Self-reported questionnaire
Participants will be answering the questionnaire once (not at a specifik age but between 18-40 years)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Christoffer Johansen, MD, PhD, DSc, Institute of Cancer Epidemiology, Danish Cancer Society
  • Study Chair: Charlotte W Appel, MSc, Institute of Cancer Epidemiology, Danish Cancer Society
  • Study Chair: Pernille E Bidstrup, PhD, Institute of Cancer Epidemiology, Danish Cancer Society
  • Study Chair: Henrik Hjalgrim, PhD, Statens Serum Institut

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

September 1, 2009

Primary Completion (Actual)

November 1, 2012

Study Completion (Actual)

November 1, 2012

Study Registration Dates

First Submitted

October 11, 2011

First Submitted That Met QC Criteria

October 14, 2011

First Posted (Estimate)

October 18, 2011

Study Record Updates

Last Update Posted (Estimate)

August 12, 2014

Last Update Submitted That Met QC Criteria

August 11, 2014

Last Verified

August 1, 2014

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 1-2009
  • 7134-08 (Other Grant/Funding Number: TrygFonden)
  • 2009-41-3506 (Other Identifier: Danish Data Protection Agency)

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Bereavement

Subscribe